What is the share price of Eiko Lifesciences Ltd (EIKO) today?
The share price of EIKO as on 17th June 2025 is ₹50.10. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Eiko Lifesciences Ltd (EIKO) share?
The past returns of Eiko Lifesciences Ltd (EIKO) share are- Past 1 week: 1.98%
- Past 1 month: -3.51%
- Past 3 months: -3.75%
- Past 6 months: -18.19%
- Past 1 year: 0.56%
- Past 3 years: 4.82%
- Past 5 years: 218.51%
What are the peers or stocks similar to Eiko Lifesciences Ltd (EIKO)?
The peers or stocks similar to Eiko Lifesciences Ltd (EIKO) include:What is the market cap of Eiko Lifesciences Ltd (EIKO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Eiko Lifesciences Ltd (EIKO) is ₹70.81 Cr as of 17th June 2025.What is the 52 week high and low of Eiko Lifesciences Ltd (EIKO) share?
The 52-week high of Eiko Lifesciences Ltd (EIKO) is ₹74.88 and the 52-week low is ₹42.What is the PE and PB ratio of Eiko Lifesciences Ltd (EIKO) stock?
The P/E (price-to-earnings) ratio of Eiko Lifesciences Ltd (EIKO) is 33.72. The P/B (price-to-book) ratio is 1.40.Which sector does Eiko Lifesciences Ltd (EIKO) belong to?
Eiko Lifesciences Ltd (EIKO) belongs to the Materials sector & Specialty Chemicals sub-sector.How to buy Eiko Lifesciences Ltd (EIKO) shares?
You can directly buy Eiko Lifesciences Ltd (EIKO) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Eiko Lifesciences Ltd
EIKO Share Price
50.100.00% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
EIKO Performance & Key Metrics
EIKO Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 34.04 | 1.40 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 27.47 | 3.49 | 1.58% |
EIKO Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
EIKO Company Profile
Eiko LifeSciences Ltd specializes in manufacturing specialty and fine chemicals, including pharma intermediates and cosmetic ingredients, catering to diverse industrial needs.
FLUOROCHEM
PE Ratio
73.05
73.05
1Y Return
10.09%
10.09%
Buy Reco %
55.56
55.56
NAVINFLUOR
PE Ratio
77.56
77.56
1Y Return
30.66%
30.66%
Buy Reco %
62.96
62.96
VINATIORGA
PE Ratio
48.05
48.05
1Y Return
0.90%
0.90%
Buy Reco %
83.33
83.33
AARTIIND
PE Ratio
50.71
50.71
1Y Return
34.01%
34.01%
Buy Reco %
70.59
70.59
PE Ratio
58.93
58.93
1Y Return
5.48%
5.48%
Buy Reco %
60.00
60.00
EIKO Forecast
EIKO Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
EIKO
EIKO
Income
Balance Sheet
Cash Flow
Annual Normal View
EIKO Income Statement
EIKO Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.40 | 0.51 | 0.39 | 0.43 | 12.45 | 26.08 | 19.17 | 28.11 | 38.72 | 38.72 | ||||||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 10.67 | 25.05 | 13.66 | 27.20 | 34.90 | 34.90 | ||||||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.10 | 0.04 | 0.07 | ||||||||||||
| Employee Cost | 0.06 | 0.07 | 0.02 | 0.07 | 0.12 | 0.23 | 0.23 | 0.16 | ||||||||||||
| Selling & Administrative Expenses | 0.08 | 0.11 | 0.17 | 0.10 | 0.20 | 0.45 | 0.42 | 0.47 | ||||||||||||
| Operating & Other expenses | 0.00 | -0.00 | 0.00 | 0.00 | 0.47 | -1.73 | 3.01 | -1.59 | ||||||||||||
EBITDA | 0.26 | 0.33 | 0.20 | 0.26 | 0.97 | 1.98 | 1.81 | 1.80 | 3.82 | 3.82 | ||||||||||
| Depreciation/Amortization | 0.02 | 0.06 | 0.06 | 0.06 | 0.06 | 0.56 | 0.63 | 0.66 | 0.74 | 0.74 | ||||||||||
| PBIT | 0.24 | 0.27 | 0.14 | 0.20 | 0.91 | 1.42 | 1.18 | 1.14 | 3.08 | 3.08 | ||||||||||
| Interest & Other Items | 0.02 | 0.05 | 0.03 | 0.07 | 0.09 | 0.48 | 0.16 | 0.15 | 0.16 | 0.17 | ||||||||||
| PBT | 0.22 | 0.22 | 0.11 | 0.13 | 0.82 | 0.94 | 1.02 | 0.99 | 2.92 | 2.91 | ||||||||||
| Taxes & Other Items | 0.06 | 0.03 | 0.03 | 0.00 | 0.22 | 0.23 | 0.26 | 0.23 | 0.82 | 0.83 | ||||||||||
| Net Income | 0.16 | 0.19 | 0.08 | 0.13 | 0.60 | 0.71 | 0.76 | 0.76 | 2.10 | 2.08 | ||||||||||
| EPS | 0.46 | 0.48 | 0.18 | 0.29 | 1.36 | 1.01 | 0.79 | 0.65 | 1.62 | 1.50 | ||||||||||
| DPS | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EIKO Company Updates
EIKO Stock Peers
EIKO Past Performance & Peer Comparison
EIKO Past Performance & Peer Comparison
Comparing 3 stocks from
MaterialsSpecialty Chemicals
Compare valuation on Screener
MaterialsSpecialty Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Eiko Lifesciences Ltd | 33.72 | 1.40 | — |
| Gujarat Fluorochemicals Ltd | 73.05 | 6.72 | — |
| Navin Fluorine International Ltd | 77.56 | 9.39 | 0.27% |
| Vinati Organics Ltd | 48.05 | 7.91 | 0.40% |
EIKO Stock Price Comparison
Compare EIKO with any stock or ETFCompare EIKO with any stock or ETF
EIKO
EIKO Holdings
EIKO Shareholdings
EIKO Promoter Holdings Trend
EIKO Promoter Holdings Trend
Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has increased by 11.83%
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
EIKO Institutional Holdings Trend
EIKO Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
EIKO Shareholding Pattern
EIKO Shareholding Pattern
EIKO Shareholding History
EIKO Shareholding History
Foreign Institutions
smallcases containing EIKO stock
smallcases containing EIKO stock
Looks like this stock is not in any smallcase yet.
EIKO Events
EIKO Events
EIKO Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
EIKO has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
EIKO Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
EIKO has not given any dividends in last 5 years
EIKO Upcoming Dividends
EIKO Upcoming Dividends
No upcoming dividends are available
EIKO Past Dividends
EIKO Past Dividends
Cash Dividend
Ex DateEx DateSep 20, 2017
Final
Final | Div/Share: ₹0.25
Dividend/Share
₹0.25
Ex DateEx Date
Sep 20, 2017
EIKO Stock News & Opinions
EIKO Stock News & Opinions
Articles & Videos
Earnings
Eiko Lifesciences standalone net profit rises 190.32% in the March 2025 quarter
Net profit of Eiko Lifesciences rose 190.32% to Rs 0.90 crore in the quarter ended March 2025 as against Rs 0.31 crore during the previous quarter ended March 2024. Sales declined 15.60% to Rs 7.09 crore in the quarter ended March 2025 as against Rs 8.40 crore during the previous quarter ended March 2024. For the full year,net profit rose 132.00% to Rs 1.74 crore in the year ended March 2025 as against Rs 0.75 crore during the previous year ended March 2024. Sales rose 16.33% to Rs 32.49 crore in the year ended March 2025 as against Rs 27.93 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales7.098.40 -16 32.4927.93 16 OPM %7.336.07 -5.235.73 - PBDT1.010.60 68 2.601.64 59 PBT0.860.42 105 1.970.98 101 NP0.900.31 190 1.740.75 132 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Eiko Lifesciences to hold board meeting
Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 14 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Eiko Lifesciences to announce Quarterly Result
Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 14 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Eiko Lifesciences standalone net profit rises 16.67% in the December 2024 quarter
Net profit of Eiko Lifesciences rose 16.67% to Rs 0.28 crore in the quarter ended December 2024 as against Rs 0.24 crore during the previous quarter ended December 2023. Sales rose 4.54% to Rs 6.91 crore in the quarter ended December 2024 as against Rs 6.61 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales6.916.61 5 OPM %6.517.11 - PBDT0.530.45 18 PBT0.380.29 31 NP0.280.24 17 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Eiko Lifesciences to discuss results
Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Eiko Lifesciences to conduct board meeting
Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 25 November 2024Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Eiko Lifesciences standalone net profit rises 75.00% in the September 2024 quarter
Net profit of Eiko Lifesciences rose 75.00% to Rs 0.21 crore in the quarter ended September 2024 as against Rs 0.12 crore during the previous quarter ended September 2023. Sales rose 20.75% to Rs 7.74 crore in the quarter ended September 2024 as against Rs 6.41 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales7.746.41 21 OPM %4.655.46 - PBDT0.450.32 41 PBT0.290.16 81 NP0.210.12 75 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Eiko Lifesciences to discuss results
Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 19 October 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Eiko Lifesciences to convene AGM
Eiko Lifesciences announced that the 47th Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Eiko Lifesciences standalone net profit rises 337.50% in the June 2024 quarter
Net profit of Eiko Lifesciences rose 337.50% to Rs 0.35 crore in the quarter ended June 2024 as against Rs 0.08 crore during the previous quarter ended June 2023. Sales rose 65.13% to Rs 10.75 crore in the quarter ended June 2024 as against Rs 6.51 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales10.756.51 65 OPM %3.814.15 - PBDT0.640.27 137 PBT0.470.11 327 NP0.350.08 338 Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 135.27%, vs industry avg of 6.1%
Over the last 5 years, market share increased from 0% to 0.03%
Over the last 5 years, net income has grown at a yearly rate of 56.87%, vs industry avg of -1.02%